NCT06003049View on ClinicalTrials.gov

A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 24, 2024

Study Completion Date

July 10, 2024

Conditions

COPD

Interventions

DRUG

OnabotulinumtoxinA

BOTOX injection series

OTHER

Placebo

Placebo injection series

Trial Locations (1)

77598

Tranquil Clinical Research, Webster

All Listed Sponsors

lead

RMW Testing

INDUSTRY